Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 20

    2 March 2020 - Applied DNA Sciences Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed

    2 March 2020 - Applied DNA Sciences Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed

    Medical Dialogues Bureau4 March 2020 10:00 AM IST
    For the induction of antibodies that can neutralize COVID-19, it is essential to use reliable, effective technologies that can be quickly adapted in...
    Strides get USFDA nod for Tetracycline Hydrochloride Capsules

    Strides get USFDA nod for Tetracycline Hydrochloride Capsules

    Medical Dialogues Bureau4 March 2020 9:30 AM IST
    Tetracycline Hydrochloride Capsule is an antibiotic used to treat many different bacterial infections of the skin, intestines, respiratory tract,...
    Thermo Fisher Scientific takes over QIAGEN N.V.

    Thermo Fisher Scientific takes over QIAGEN N.V.

    Medical Dialogues Bureau4 March 2020 9:00 AM IST
    Waltham and Venlo: Thermo Fisher Scientific Inc. and QIAGEN N.V. a global provider of molecular diagnostics and sample preparation technologies have...
    AI-driven Healthcare Analytics firm Tricog raises 76 crores(approx.) in Series B Funding

    AI-driven Healthcare Analytics firm Tricog raises 76 crores(approx.) in Series B Funding

    Medical Dialogues Bureau3 March 2020 2:30 PM IST
    Tricog leverages its deep medical and technology expertise, to provide Virtual Cardiology Services to remote clinics, powered by ground-breaking AI...
    Shortage of generic version of BP drug pindolol, says Sun Pharma

    Shortage of generic version of BP drug pindolol, says Sun Pharma

    Medical Dialogues Bureau3 March 2020 12:36 PM IST
    The coronavirus outbreak has disrupted international businesses dependent on Chinese supplies and industry experts expect Indian generic drugmakers to...
    Piramal receives Rs 6500 crores on completion of sale of its DRG business

    Piramal receives Rs 6500 crores on completion of sale of its DRG business

    Medical Dialogues Bureau3 March 2020 10:45 AM IST
    PEL DRG Dutch HoldCo BV, a 100 per cent subsidiary of Piramal Enterprises Ltd (PEL) and the holding company for DRG, had signed the definitive...
    Novartis updates on uses and safety of Beovu in patients with wet AMD

    Novartis updates on uses and safety of Beovu in patients with wet AMD

    Medical Dialogues Bureau3 March 2020 10:00 AM IST
    If clinical signs of intraocular inflammation or changes in vision after Beovu injection are observed doctor should perform the appropriate diagnostic...
    Ficci calls for preventive measures of coronavirus in India

    Ficci calls for preventive measures of coronavirus in India

    Medical Dialogues Bureau3 March 2020 9:00 AM IST
    New Delhi: Industry body Ficci has recently called for measures to prevent the spread of deadly coronavirus in India, even as two more cases -- one in...
    Dr VG Somani DCGI releases IPA guidelines on Market Complaints.

    Dr VG Somani DCGI releases IPA guidelines on Market Complaints.

    Medical Dialogues Bureau2 March 2020 10:30 AM IST
    The guidelines were released at the recently concluded India Pharmaceutical Forum
    Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.

    Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.

    Medical Dialogues Bureau2 March 2020 10:15 AM IST
    San Diego: Illumina, Inc. today announced that it has filed a patent infringement suit relating to BGI's "CoolMPS" sequencing products. The complaint...
    Philips, European Society of Radiology to host Ultrasound Academy at ECR 2020

    Philips, European Society of Radiology to host Ultrasound Academy at ECR 2020

    Medical Dialogues Bureau2 March 2020 9:00 AM IST
    Amsterdam and Vienna: Royal Philips a global leader in health technology, and the European Society of Radiology (ESR), have announced a collaboration...
    COVID-19: USFDA updates about supply chain effect on medicines, devices and PPE

    COVID-19: USFDA updates about supply chain effect on medicines, devices and PPE

    Medical Dialogues Bureau1 March 2020 2:45 PM IST
    A manufacturer has alerted that a shortage of a human drug that was recently added to the drug shortages list.
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok